Surgical Correction of Moderate Ischemic Mitral Regurgitation

This study has been completed.
Sponsor:
Information provided by:
Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
NCT00394797
First received: October 31, 2006
Last updated: May 31, 2011
Last verified: May 2011
  Purpose

The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.


Condition Intervention
Moderate Ischemic Mitral Regurgitation
Procedure: mitral valve annuloplasty

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Further study details as provided by Shaare Zedek Medical Center:

Primary Outcome Measures:
  • survival at 1,5 and 10 years

Secondary Outcome Measures:
  • event free survival
  • symptoms
  • echocardiographic parameters

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Sampling Method:   Probability Sample
Study Population

Patients undergoing coronary bypass surgery who have moderate degree of ischemic MR

Criteria

Inclusion Criteria:

  • patients undergoing coronary bypass surgery who have moderate degree of ischemic MR

Exclusion Criteria:

  • etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00394797

Locations
Israel
Shaare Zedek Medical Center
Jerusalem, Israel, 91031
Sponsors and Collaborators
Shaare Zedek Medical Center
Investigators
Principal Investigator: Shuli Silberman, MD Shaare Zedek Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00394797     History of Changes
Other Study ID Numbers: IMR001
Study First Received: October 31, 2006
Last Updated: May 31, 2011
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Ischemia
Mitral Valve Insufficiency
Pathologic Processes
Heart Valve Diseases
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 14, 2014